More on IMGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.1 Score)
- Holders
- Event Driven Deals
- FDA

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (6/30/24 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IMGN Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 196M
Accounts receivable 316K
Unbilled revenue
Inventory 2.03M
Restricted cash
Prepaid and other current assets 7.48M
Total current assets 207.28M
Property and equipment, net of accumulated depreciation 20.93M
Long-term restricted cash
Other assets 3.13M
Total assets 231.35M
Accounts payable 8.97M
Accrued compensation 6.75M
Other accrued liabilities 10.02M
Current portion of deferred lease incentive
Current portion of deferred revenue 13.63M
Total current liabilities 56.23M
Deferred lease incentive, net of current portion
Deferred revenue, net of current portion 19.16M
Other long-term liabilities 4.1M
Total liabilities 353.89M
Commitments and contingencies (Note E) 0
Preferred stock, $.01 par value; authorized 5,000 shares; no shares issued and outstanding
Common stock, $.01 par value; authorized 100,000 shares; issued and outstanding 76,422 and 76,281 shares as of September 30, 2011 and June 30, 2011, respectively 873K
Additional paid-in capital 775.01M
Accumulated deficit -898.42M
Total shareholders' equity -122.54M
Total liabilities and shareholders' equity 231.35M